Document is current
Any future updates will be listed below
-
Authors
Ashton, Nicholas J.
Suárez-Calvet, Marc
Heslegrave, Amanda
Hye, Abdul
Razquin, Cristina
Pastor, Pau
Sanchez-Valle, Raquel
Molinuevo, José L.
Visser, Pieter Jelle
Blennow, Kaj
Hodges, Angela K.
Zetterberg, Henrik
- License Information
-
More Information
Article History
Received: 11 June 2019
Accepted: 9 October 2019
First Online: 28 November 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: KB has served as a consultant or at advisory boards for Alector, Alzheon, CogRx, Biogen, Lilly, Novartis and Roche Diagnostics, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Venture-based platform company at the University of Gothenburg, all unrelated to the work presented in this paper. HZ has served at scientific advisory boards for Roche Diagnostics, Wave, Samumed and CogRx; has given lectures in symposia sponsored by Alzecure and Biogen; and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Venture-based platform company at the University of Gothenburg. The other authors declare that they have no competing interests.
